These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 18599000)

  • 1. Infliximab in Crohn's disease: early and long-term treatment.
    Armuzzi A; De Pascalis B; Fedeli P; De Vincentis F; Gasbarrini A
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S271-9. PubMed ID: 18599000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
    Vermeire S; van Assche G; Rutgeerts P
    Aliment Pharmacol Ther; 2007 Jan; 25(1):3-12. PubMed ID: 17229216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 5-year prospective observational study of the outcomes of international treatment guidelines for Crohn's disease.
    Cullen G; Keegan D; Mulcahy HE; O'Donoghue DP
    Clin Gastroenterol Hepatol; 2009 Mar; 7(3):323-8; quiz 252. PubMed ID: 19174193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the optimal therapy for Crohn's disease: step-up or top-down?
    Lin MV; Blonski W; Lichtenstein GR
    Expert Rev Gastroenterol Hepatol; 2010 Apr; 4(2):167-80. PubMed ID: 20350264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical therapy for Crohn's disease: top-down or step-up?
    Baert F; Caprilli R; Angelucci E
    Dig Dis; 2007; 25(3):260-6. PubMed ID: 17827952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early or late guided missile in the treatment of Crohn's disease?
    Caprilli R; Angelucci E; Cocco A
    Dig Liver Dis; 2005 Dec; 37(12):973-9. PubMed ID: 16169305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical perspectives in Crohn's disease. Turning traditional treatment strategies on their heads: current evidence for "step-up" versus "top-down".
    Hanauer SB
    Rev Gastroenterol Disord; 2007; 7 Suppl 2():S17-22. PubMed ID: 17392635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab.
    Persoons P; Vermeire S; Demyttenaere K; Fischler B; Vandenberghe J; Van Oudenhove L; Pierik M; Hlavaty T; Van Assche G; Noman M; Rutgeerts P
    Aliment Pharmacol Ther; 2005 Jul; 22(2):101-10. PubMed ID: 16011668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance of medically induced remission of Crohn's disease.
    Gonvers JJ; Juillerat P; Mottet C; Pittet V; Felley C; Vader JP; Michetti P; Froehlich F
    Digestion; 2007; 76(2):116-29. PubMed ID: 18239403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early treatment in Crohn's disease: do we have enough evidence to reverse the therapeutic pyramid?
    Fascì Spurio F; Aratari A; Margagnoni G; Doddato MT; Papi C
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):67-73. PubMed ID: 22457862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological therapies in inflammatory bowel disease: top-down or bottom-up?
    Oldenburg B; Hommes D
    Curr Opin Gastroenterol; 2007 Jul; 23(4):395-9. PubMed ID: 17545775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
    Gaertner WB; Decanini A; Mellgren A; Lowry AC; Goldberg SM; Madoff RD; Spencer MP
    Dis Colon Rectum; 2007 Nov; 50(11):1754-60. PubMed ID: 17899271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: Medical therapy for fistulizing Crohn's disease.
    Bressler B; Sands BE
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1283-93. PubMed ID: 17059510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term partial remission of autoimmune thrombocytopenia in a patient treated with the anti-tumor necrosis factor-alpha antibody infliximab for refractory fistulizing Crohn's disease.
    de Rossi TM; Krauss N; Voll RE; Nägel A; Weidenhiller M; Konturek PC; Hahn EG; Raithel M
    Digestion; 2008; 78(4):195-200. PubMed ID: 19122456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks and benefits of infliximab for the treatment of Crohn's disease.
    Siegel CA; Hur C; Korzenik JR; Gazelle GS; Sands BE
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1017-24; quiz 976. PubMed ID: 16843733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing complicated Crohn's disease in children and adolescents.
    Homan M; Baldassano RN; Mamula P
    Nat Clin Pract Gastroenterol Hepatol; 2005 Dec; 2(12):572-9. PubMed ID: 16327836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review.
    Gisbert JP; Panés J
    Am J Gastroenterol; 2009 Mar; 104(3):760-7. PubMed ID: 19174781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infliximab in the treatment of Crohn's disease -- a practical approach. Infliximab and chronic Crohn's disease--Consensus statement of the Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH].
    Tilg H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W;
    Z Gastroenterol; 2004 Oct; 42(10):1256-63. PubMed ID: 15508068
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines for treatment with infliximab for Crohn's disease.
    Hommes DW; Oldenburg B; van Bodegraven AA; van Hogezand RA; de Jong DJ; Romberg-Camps MJ; van der Woude J; Dijkstra G;
    Neth J Med; 2006; 64(7):219-29. PubMed ID: 16929083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of luminal and fistulizing Crohn's disease with infliximab.
    Comerford LW; Bickston SJ
    Gastroenterol Clin North Am; 2004 Jun; 33(2):387-406, xi. PubMed ID: 15177545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.